FCP - The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent
Voici un article paru récemment dans FCP:
"The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent"
Bonne lecture!
- Dernière mise à jour le .